The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
Access Rights
info:eu-repo/semantics/closedAccess
DOI
Abstract
Description
43rd ESMO Congress (ESMO) -- OCT 19-23, 2018 -- Munich, GERMANY
WOS: 000459277303171
WOS: 000459277303171
Keywords
Journal or Series
43rd ESMO Congress (ESMO)
WoS Q Value
Scopus Q Value
Volume
29
Issue
Supplement: 8
Citation
Kılıçkap, S., Ölmez, Ö. F., Cicin, İ., Demirci, U., Alan, O., Çabuk, D. ... Sakin, A. (2018). The efficacy and safety of crizotinib in patients with ROS1 positive advanced stage NSCLC: The real-world experience from Turkey. 43rd ESMO Congress (ESMO) içinde (505-505. ss.). Munich, Germany, October 19-23, 2018.
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
info:eu-repo/semantics/closedAccess
